Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Attila Mihalyi, Peter Simsa, Kyama C Mutinda, Christel Meuleman, Jason M Mwenda & Thomas M D’Hooghe. (2006) Emerging drugs in endometriosis. Expert Opinion on Emerging Drugs 11:3, pages 503-524.
Read now
Read now
Kosuke Shimizu, Tomohiro Asai & Naoto Oku. (2005) Antineovascular therapy, a novel antiangiogenic approach. Expert Opinion on Therapeutic Targets 9:1, pages 63-76.
Read now
Read now
William F Anderson, Asad Umar & Ernest T Hawk. (2003) Cyclooxygenase inhibition in cancer prevention and treatment. Expert Opinion on Pharmacotherapy 4:12, pages 2193-2204.
Read now
Read now
Kefah Mokbel. (2003) Recent advances in breast cancer: the 27th ESMO Congress 2002. Current Medical Research and Opinion 19:2, pages 141-142.
Read now
Read now
G. Singh-Ranger, K. L. Kirkpatrick, G. M. Clark & K. Mokbel. (2003) Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer. Current Medical Research and Opinion 19:2, pages 131-134.
Read now
Read now
Articles from other publishers (58)
Eshan A. Narasipura, Rachel VanKeulen-Miller, Yutian Ma & Owen S. Fenton. (2023) Ongoing Clinical Trials of Nonviral siRNA Therapeutics. Bioconjugate Chemistry 34:7, pages 1177-1197.
Crossref
Crossref
Louise Benoit, Florence Jornod, Elias Zgheib, Celine Tomkiewicz, Meriem Koual, Thibaut Coustillet, Robert Barouki, Karine Audouze, Mathieu Vinken & Xavier Coumoul. (2022) Adverse outcome pathway from activation of the AhR to breast cancer-related death. Environment International 165, pages 107323.
Crossref
Crossref
Soheila Safarpour, Samaneh Safarpour, Ali A. Moghadamnia, Sohrab Kazemi, Anahita Ebrahimpour, Fatemeh Shirafkan, Razieh Mansoori & Ravieh Golchoobian. (2022) Cardioprotective effect of silymarin nanoemulsion on 5‐fluorouracil‐induced cardiotoxicity in rats. Archiv der Pharmazie 355:7.
Crossref
Crossref
Ewelina Gorowska-Wojtowicz, Michal Duliban, Malgorzata Kotula-Balak & Barbara Bilinska. (2022) Modulatory Effects of Estradiol and Its Mixtures with Ligands of GPER and PPAR on MAPK and PI3K/Akt Signaling Pathways and Tumorigenic Factors in Mouse Testis Explants and Mouse Tumor Leydig Cells. Biomedicines 10:6, pages 1390.
Crossref
Crossref
Soheila Safarpour, Marzieh Pirzadeh, Anahita Ebrahimpour, Fatemeh Shirafkan, Fateme Madani, Mohammad Hosseini, Ali Akbar Moghadamnia & Sohrab Kazemi. (2022) Protective Effect of Kaempferol and Its Nanoparticles on 5-Fluorouracil-Induced Cardiotoxicity in Rats. BioMed Research International 2022, pages 1-13.
Crossref
Crossref
Soheila Safarpour, Samaneh Safarpour, Marzieh Pirzadeh, Ali Akbar Moghadamnia, Anahita Ebrahimpour, Fatemeh Shirafkan, Razieh Mansoori, Sohrab Kazemi & Mohammad Hosseini. (2022) Colchicine Ameliorates 5-Fluorouracil-Induced Cardiotoxicity in Rats. Oxidative Medicine and Cellular Longevity 2022, pages 1-13.
Crossref
Crossref
Tatiany L. Silveira, Emerson S. Veloso, Ivy N. N. Gonçalves, Renato F. Costa, Michele A. Rodrigues, Geovanni D. Cassali, Helen L. Del Puerto, Lisa Y. Pang, David J. Argyle & Enio Ferreira. (2020) Cyclooxygenase‐2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas. Veterinary and Comparative Oncology 18:4, pages 727-738.
Crossref
Crossref
Abdulrahman Alwhaibi, Arti Verma, Mir S. Adil & Payaningal R. Somanath. (2019) The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis. Pharmacological Research 145, pages 104270.
Crossref
Crossref
T. P. Raposo, I. Pires, J. Prada, F. L. Queiroga & D. J. Argyle. (2016) Exploring new biomarkers in the tumour microenvironment of canine inflammatory mammary tumours. Veterinary and Comparative Oncology 15:2, pages 655-666.
Crossref
Crossref
M. I. Carvalho, I. Pires, J. Prada, T. P. Raposo, H. Gregório, L. Lobo & F. L. Queiroga. (2016)
High
COX
‐2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study
. Veterinary and Comparative Oncology 15:2, pages 619-631.
Crossref
Crossref
Yan Li, Jinghui Wang, Feng Lin, Yinfeng Yang & Su-Shing Chen. (2017) A Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese Medicines. PLOS ONE 12:1, pages e0169363.
Crossref
Crossref
Sandrine Tury, Véronique Becette, Franck Assayag, Sophie Vacher, Camille Benoist, Maud Kamal, Elisabetta Marangoni, Ivan Bièche, Florence Lerebours & Céline Callens. (2016)
Combination of COX-2 expression and
PIK3CA
mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
. Oncotarget 7:51, pages 85124-85141.
Crossref
Crossref
Zhongxing Liang, Xuehai Bian & Hyunsuk Shim. (2016) Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer. Biochemical and Biophysical Research Communications 477:3, pages 461-466.
Crossref
Crossref
Paramahamsa Maturu. 2016. Wilms Tumor. Wilms Tumor
189
207
.
YANYAN ZHU, MEIYAN GUO, LINGYUN ZHANG, TAO XU, LI WANG & GUOXIONG XU. (2016) Biomarker triplet NAMPT/VEGF/HER2 as a de novo detection panel for the diagnosis and prognosis of human breast cancer. Oncology Reports 35:1, pages 454-462.
Crossref
Crossref
Chun-Xiong Zhao, Chun-Li Luo & Xiao-Hou Wu. (2014) Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2. Medical Oncology 32:1.
Crossref
Crossref
Paramahamsa Maturu, Willem W. Overwijk, John Hicks, Suhendan Ekmekcioglu, Elizabeth A. Grimm & Vicki Huff. (2014) Characterization of the Inflammatory Microenvironment and Identification of Potential Therapeutic Targets in Wilms Tumors. Translational Oncology 7:4, pages 484-492.
Crossref
Crossref
HONG ZHANG, ZHIHONG LI & KAIZHONG WANG. (2014) Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo. Oncology Reports 31:4, pages 1954-1960.
Crossref
Crossref
QIANG ZHANG, XIANYING MENG, GUIBIN ZHENG, GUANG CHEN, RENZHU PANG, TEBO HUA & SHUAI YANG. (2014) Antitumor activity of celecoxib, a selective cyclooxygenase-2 inhibitor, in medullary thyroid carcinoma. Molecular Medicine Reports 9:2, pages 768-772.
Crossref
Crossref
Randall E Harris. (2014) Cyclooxygenase-2 and the inflammogenesis of breast cancer. World Journal of Clinical Oncology 5:4, pages 677.
Crossref
Crossref
B N Prashanth Kumar, Shashi Rajput, Kaushik Kumar Dey, Aditya Parekh, Subhasis Das, Abhijit Mazumdar & Mahitosh Mandal. (2013) Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. BMC Cancer 13:1.
Crossref
Crossref
Aline Corrêa Abrahão, Fernanda Salgueiredo Giudice, Felipe Fornias Sperandio & Décio dos Santos Pinto Junior. (2013) Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma. Journal of Oral Pathology & Medicine 42:10, pages 793-798.
Crossref
Crossref
Mónica Clemente, Ana Rodríguez Sánchez-Archidona, David Sardón, Lucía Díez, Asunción Martín-Ruiz, Sara Caceres, Francesco Sassi, M. Dolores Pérez-Alenza, Juan C. Illera, Susana Dunner & Laura Peña. (2013) Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer. The Veterinary Journal 197:2, pages 427-432.
Crossref
Crossref
Qinwen Wang, Xinwei Diao, Jianguo Sun & Zhengtang Chen. (2013) Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy. Urologic Oncology: Seminars and Original Investigations 31:3, pages 312-317.
Crossref
Crossref
Louise R. Howe. 2013. Obesity, Inflammation and Cancer. Obesity, Inflammation and Cancer
257
303
.
Felisbina L. Queiroga, Isabel Pires, Margarida Parente, Hugo Gregório & Carlos S. Lopes. (2011) COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer. The Veterinary Journal 189:1, pages 77-82.
Crossref
Crossref
Daniel Escorsim Machado, Plínio Tostes Berardo, Richardt Gama Landgraf, Patrícia Dias Fernandes, Celia Palmero, Leandro Miranda Alves, Maurício Simões Abrao & Luiz Eurico Nasciutti. (2010) A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model. Fertility and Sterility 93:8, pages 2674-2679.
Crossref
Crossref
Jiacong You, Da Mi, Xiaolei Zhou, Ling Qiao, Hang Zhang, Xiaodong Zhang & Lihong Ye. (2009) A Positive Feedback between Activated Extracellularly Regulated Kinase and Cyclooxygenase/Lipoxygenase Maintains Proliferation and Migration of Breast Cancer Cells. Endocrinology 150:4, pages 1607-1617.
Crossref
Crossref
Y. Rebecca Chin & Alex Toker. (2009) Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cellular Signalling 21:4, pages 470-476.
Crossref
Crossref
Seyit Temel Ceyhan, Onder Onguru, İskender Baser & Omer Gunhan. (2008) Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis. Fertility and Sterility 90:4, pages 988-993.
Crossref
Crossref
Zeina Nahleh, Azadeh Namakydoust, Rania Bakkar & John Bishop. (2007) Trastuzumab not for ductal carcinoma in situ?. Anti-Cancer Drugs 18:10, pages 1231-1235.
Crossref
Crossref
M. Salhab, G. Singh‐Ranger, R. Mokbel, F. Jouhra, W.G. Jiang & K. Mokbel. (2007) Cyclooxygenase‐2 mRNA expression correlates with aromatase expression in human breast cancer. Journal of Surgical Oncology 96:5, pages 424-428.
Crossref
Crossref
Zhongxing Liang, Joann Brooks, Margaret Willard, Ke Liang, Younghyoun Yoon, Seunghee Kang & Hyunsuk Shim. (2007) CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochemical and Biophysical Research Communications 359:3, pages 716-722.
Crossref
Crossref
Yuxin Li & Powel H. Brown. (2007) Translational approaches for the prevention of estrogen receptor-negative breast cancer. European Journal of Cancer Prevention 16:3, pages 203-215.
Crossref
Crossref
Jonathan M. Bock, Sarita G. Menon, Lori L. Sinclair, Nichole S. Bedford, Prabhat C. Goswami, Frederick E. Domann & Douglas K. Trask. (2007) Celecoxib Toxicity Is Cell Cycle Phase Specific. Cancer Research 67:8, pages 3801-3808.
Crossref
Crossref
F.L. Queiroga, A. Alves, I. Pires & C. Lopes. (2007) Expression of Cox-1 and Cox-2 in Canine Mammary Tumours. Journal of Comparative Pathology 136:2-3, pages 177-185.
Crossref
Crossref
B H A von Rahden, B L D M Brücher, C Langner, J R Siewert, H J Stein & M Sarbia. (2006) Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor β1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine. British Journal of Surgery 93:11, pages 1424-1432.
Crossref
Crossref
M. Brunelle, E. A. Sartin, L. G. Wolfe, J. Sirois & M. Doré. (2016) Cyclooxygenase-2 Expression in Normal and Neoplastic Canine Mammary Cell Lines. Veterinary Pathology 43:5, pages 656-666.
Crossref
Crossref
F. Millanta, S. Citi, D. Della Santa, M. Porciani & A. Poli. (2006) COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic fmolecular markers. Breast Cancer Research and Treatment 98:1, pages 115-120.
Crossref
Crossref
A V Timoshenko, C Chakraborty, G F Wagner & P K Lala. (2006) COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. British Journal of Cancer 94:8, pages 1154-1163.
Crossref
Crossref
Hyuk-Moon KimHee-Doo WooDoo-Min SohnSung-Yong KimCheol-Wan LimRae-Kyung ParkSung-Pil JungMin-Hyuk Lee. (2006) Inhibitory Effect on Angiogenesis of a Selective Cyclooxygenase-2 Inhibitor with using Mouse Mammary Tumor cells. Journal of Breast Cancer 9:3, pages 206.
Crossref
Crossref
Louise R. Howe, Sung-Hee Chang, Kelly C. Tolle, Rachelle Dillon, Lawrence J.T. Young, Robert D. Cardiff, Robert A. Newman, Peiying Yang, Howard T. Thaler, William J. Muller, Clifford Hudis, Anthony M.C. Brown, Timothy Hla, Kotha Subbaramaiah & Andrew J. Dannenberg. (2005) HER2/neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice. Cancer Research 65:21, pages 10113-10119.
Crossref
Crossref
T. Chi-Man Tang, R. Tung-Ping Poon & S.-T. Fan. (2005) The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma. Biomedicine & Pharmacotherapy 59, pages S311-S316.
Crossref
Crossref
Attila Mihalyi, Kyama C Mutinda, Peter Simsa, Sophie Debrock, Jason M Mwenda & Thomas M D’Hooghe. (2005) Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies. Therapy 2:4, pages 623-639.
Crossref
Crossref
Burkhard H.A. von Rahden, Hubert J. Stein, Franziska Pühringer, Ina Koch, Rupert Langer, Guido Piontek, J. Rüdiger Siewert, Heinz Höfler & Mario Sarbia. (2005) Coexpression of Cyclooxygenases (COX-1, COX-2) and Vascular Endothelial Growth Factors (VEGF-A, VEGF-C) in Esophageal Adenocarcinoma. Cancer Research 65:12, pages 5038-5044.
Crossref
Crossref
Harry Applebaum, Mark W. Kieran, Timothy P. Cripe, Cheryl M. Coffin, Margaret H. Collins, Arja Kaipainen, Andrea Laforme & Robert C. Shamberger. (2005) The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study. Journal of Pediatric Surgery 40:6, pages 999-1003.
Crossref
Crossref
G Perrone, D Santini, B Vincenzi, M Zagami, A La Cesa, A Bianchi, V Altomare, A Primavera, C Battista, A Vetrani, G Tonini & C Rabitti. (2005) COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features. Histopathology 46:5, pages 561-568.
Crossref
Crossref
Rouba Ali-Fehmi, Robert T. Morris, Sudeshna Bandyopadhyay, Mingxin Che, Veronica Schimp, John M. MaloneJr.Jr. & Adnan R. Munkarah. (2005) Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: Correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival. American Journal of Obstetrics and Gynecology 192:3, pages 819-825.
Crossref
Crossref
Gurpreet Singh Ranger, Andrew Jewell, Valerie Thomas & Kefah Mokbel. (2004) Elevated expression of cyclooxygenase‐2 in breast cancer and ductal carcinoma in situ has no correlation with established prognostic markers. Journal of Surgical Oncology 88:2, pages 100-103.
Crossref
Crossref
Erbil Dogan, Uğur Saygili, Cemal Posaci, Burcin Tuna, Sezer Caliskan, Sabahattin Altunyurt & Bahadir Saatli. (2004) Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertility and Sterility 82, pages 1115-1120.
Crossref
Crossref
Hye Jung Kim & Tae-Yoon Kim. (2004) IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway. Journal of Investigative Dermatology 123:3, pages 547-555.
Crossref
Crossref
William W. Li. 2004. Cancer Chemoprevention. Cancer Chemoprevention
611
633
.
Mohammad Atiqur Rahman & Masakazu Toi. (2003) Anti-angiogenic therapy in breast cancer. Biomedicine & Pharmacotherapy 57:10, pages 463-470.
Crossref
Crossref
Mario Romano & Joan Clària. (2003) Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. The FASEB Journal 17:14, pages 1986-1995.
Crossref
Crossref
Gurpreet Singh Ranger & Kefah Mokbel. (2003)
COX‐2
inhibitors and breast cancer
. ANZ Journal of Surgery 73:8, pages 565-566.
Crossref
Crossref
Zenta Walther. (2003) COX-2 and Angiogenesis in Gastric Cancer. Journal of Clinical Gastroenterology 37:1, pages 4-6.
Crossref
Crossref
Zhi-jun Dai, Xi-jing Wang, Xiao-xu Liu, Hua-feng Kang, Jina-tao Jiang, Hai-tao Guan, Shu-qun Zhang, Xing-huan Xue & Feng-jie Xue. (2003) Up-regulation of cyclooxygenase-2 gene expression correlates with tumor angiogenesis in human breast cancer. Chinese Journal of Cancer Research 15:2, pages 149-151.
Crossref
Crossref
Ming-Yi Li. (2003) PPARγ pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. World Journal of Gastroenterology 9:6, pages 1220.
Crossref
Crossref